Temporal gene expression following prosthetic arterial grafting

Journal of Surgical Research

Volumn 120, Issue 1, 2004, Pages 27-36

  Willis, David J ^a,c   Kalish, Jeffrey A ^a   Li, Cheng ^a,b   Deutsch, Evan R ^a   Contreras, Mauricio A ^a   LoGerfo, Frank W ^a   Quist, William C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

gene expression; intimal hyperplasia; microarray; neointima; prosthetic arterial grafting; vascular smooth muscle

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 2; ISOPROTEIN; MARCKS PROTEIN; OLIGONUCLEOTIDE; OSTEOPONTIN; POLITEF; RNA; SMOOTHELIN; TROPOMYOSIN 2; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANASTOMOSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY TRANSPLANTATION; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; DNA MICROARRAY; DOG; DOWN REGULATION; EVALUATION; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; IMPLANTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SAMPLING; SURGICAL TECHNIQUE; UNINDEXED SEQUENCE; UPREGULATION;

ANASTOMOSIS, SURGICAL; ANIMALS; ARTERIES; BLOOD VESSEL PROSTHESIS IMPLANTATION; CYTOKINES; DOGS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GROWTH SUBSTANCES; MODELS, ANIMAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TIME FACTORS;

EID: 2542429226     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jss.2003.12.014     Document Type: Article

References (40)

1. Ip J.H., Fuster V., Badimon L., et al. Syndromes of accelerated atherosclerosis Role of vascular injury and smooth muscle cell proliferation. J. Am. Coll. Cardol. 15:1990;1667
2. Nobuyoshi M., Kimura T., Ohishi H., et al. Restenosis after percutaneous transluminal coronary angioplasty Pathologic observations in 20 patients. J. Am. Coll. Cardiol. 17:1991;433
3. LoGerfo F.W., Grawshaw H.M., Quist W.C., et al. Downstream anastomotic hyperplasia a mechanism of failure in Dacron arterial grafts. Ann. Surg. 1197:1983;479
4. Imparato A.M., Bracco A., Kim G.F., et al. Intimal and neointimal fibrous proliferation causing failure of arterial reconstruction. Surgery. 72:1972;1007
5. Clowes A.W., Gown A.M., Hanson S.R., et al. Mechanisms of arterial graft failure. Role of cellular proliferation in early healing of PTFE prostheses. Am. J. Pathol. 118:1985;43
6. Clowes A.W., Kirkman T.R., Clowes M.M. Mechanisms of arterial graft failure II. Chronic endothelial and smooth muscle cell proliferation in healing polytetrafluoroethylene prostheses. J. Vasc. Surg. 3:1986;877
7. Berger K., Sauvage L.R., Rao A., et al. Healing of arterial prosthesis in man Its incompleteness. Ann. Surg. 175:1972;118
8. Casscells W. Migration of smooth muscle and endothelial cells. Critical events in restenosis. Circulation. 86:1992;723
9. Lemson M.S., Tordoir J.H., Daemen M.J., et al. Intimal hyperplasia in vascular grafts. Eur. J. Vasc. Endovasc. Surg. 19:2000;336
10. Clowes A.W. Intimal hyperplasia and graft failure. Cardiovasc. Pathol. 2:1993;179S
11. Newby A.C., Zaltsman A.B. Molecular mechanisms in intimal hyperplasia. J. Pathol. 190:2000;300
12. Hamden A.D., Aiello L.P., Quist W.C., et al. Isolation of genes differentially expressed at the downstream anastomosis of prosthetic arterial grafts with use of mRNA differential display. J. Vasc. Surg. 21:1995;228
13. Cordero J.A., Quist W.C., Hamden A.D., et al. Identification of multiple genes with altered expression at the distal anastomosis of healing polytetrafluoroethylene grafts. J. Vasc. Surg. 28:1998;157
14. Stone D.H., Sivamurthy N., Contreras M.A., et al. Altered ubiquitin/proteasome expression in anastomotic intimal hyperplasia. J. Vasc. Surg. 34:2001;1016
15. Quackenbush J. Computational analysis of microarray data. Nat. Rev. Genet. 2:2001;418
16. Wodicka L., et al. A Genome-wide expression monitoring in Saccharomyces cerevisiae. Nat. Biotechnol. 15:1997;1359
17. Affymetrix Technical Note New Statistical Algorithms for Monitoring Gene Expression on GeneChip® Probe Arrays. 2001
18. Li C., Wong W.H. Model-based analysis of oligonucleotide arrays Expression index computation and outlier detection. Proc. Natl. Acad. Sci. USA. 98:2001;31
19. Tusher V.G., Tibshirani R., Chu G. Significance analysis of microarrays applied to ionizing radiation response. Proc. Natl. Acad. Sci. USA. 98:(9):2001;5116
20. Geary R.L., Wong J.M., Rossini A., et al. Expression profiling identifies 147 genes contributing to a unique primate neointimal smooth muscle cell phenotype. Arterioscler. Thromb. Vasc. Biol. 22:2002;2010
21. Zhao Y., Neltner B.S., Davis H.W. Role of MARCKS in regulating endothelial cell proliferation. Am. J. Physiol. Cell Physiol. 279:2000;C1611
22. Isoda K., Nishikawa K., Kamezawa Y., et al. Osteopontin plays an important role in the development of medial thickening and neointimal formation. Circ. Res. 91:2002;77
23. Maekawa S., Murofushi H., Nakamura S. Inhibitory effect of calmodulin on phosphorylation of NAP-22 with protein kinase C. J. Biol. Chem. 269:1994;19462
24. Comeau M.R., Johnson R., DuBose R.F., et al. A poxvirus-encoded semaphoring induces cytokine production from monocytes and binds to a novel cellular semaphoring receptor, VESPR. Immunity. 8:1998;473
25. Autieri M.V., Carbone C.M. Overexpression of allograft inflammatory factor-1 promotes proliferation of vascular smooth muscle cells by cell cycle deregulation. Arterioscler. Thromb. Vasc. Biol. 21:2001;1421
26. Bar H., Wende P., Watson L., et al. Smoothelin is an indicator of reversible phenotype modulation of smooth muscle cells in balloon-injured rat carotid arteries. Basic Res. Cardiol. 97:2002;9
27. van der Loop F.T.L., Gabbiani G., Kohnen G., et al. Differentiation of smooth muscle cells in human blood vessels as defined by smoothelin, a novel marker for the contractile phenotype. Arterioscler. Thromb. Vasc. Biol. 17:1997;665
28. Campbell B.G., Wootton J.A., MacLeod J.N., Minor R.R. Sequence of normal canine COL1A1 cDNA and identification of a heterozygous alpha1(I) collagen Gly208Ala mutation in a severe case of canine osteogenesis imperfecta. Arch. Biochem. Biophys. 384:(1):2000;37
29. Campbell B.G., Wootton J.A., MacLeod J.N., Minor R.R. Sequence of canine COL1A2 cDNA Nucleotide substitutions affecting the cyanogen bromide peptide map of the alpha 2(I) chain. Arch. Biochem. Biophys. 357:(1):1998;67
30. Autieri M.V. cDNA cloning of human allograft inflammatory factor-1 Tissue distribution, cytokine induction, and mRNA expression in injured rate carotid arteries. Biochem. Biophys. Res. Commun. 228:1996;29
31. Autieri M.V., Carbone C., Mu A. Expression of allograft inflammatory factor-1 is a marker of activated human vascular smooth muscle cells and arterial injury. Arterioscler. Thromb. Vasc. Biol. 20:2000;1737
32. Hamada K., Oike Y., Ito Y., et al. Distinct roles of Ephrin-B2 forward and EphB4 reverse signaling in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 23:2003;190
33. Levy S.E., Muldowney J.A. Microarray analysis of neointima Flowing toward a clear future. Arterioscler. Thromb. Vasc. Biol. 22:2002;1946
34. Luzzi V., Mahadevappa M., Raja R., et al. Accurate and reproducible gene expression profiles from laser capture microdissection, transcript amplification, and high density oligonucleotide microarray analysis. J. Mol. Diagn. 5:2003;9
35. Abbott W.M., Callow A., Moore W., et al. Evaluation and performance standards for arterial prostheses. J. Vasc. Surg. 17:1993;746
36. Ostrander E.A., Galibert F., Patterson D.F. Canine genetics comes of age. Trends Genet. 16:2000;117
37. Chismar J.D., Mondala T., Fox H.S., et al. Analysis of result variability from high-density oligonucleotide arrays comparing same-species and cross-species hybridizations. Biotechniques. 33:(3):2002;516
38. Lipshutz R.J., Fodor S.P., Gingeras T.R., et al. High density synthetic oligonucleotide arrays. Nat. Genet. 21:1999;20
39. Lee C.K., Weindruch R., Prolla T.A. Gene-expression profile of the ageing brain in mice. Nature Genet. 25:2000;294
40. Kuo W.P., Jenssen T.K., Butte A.J., et al. Analysis of matched mRNA measurements from two different microarray technologies. Bioinformatics. 18:2002;405